A phase 3 randomized clinical trial using a o nce‐weekly glucagon‐like peptide‐1 receptor agonist in adolescents and young adults with hypothalamic obesity-Reference-Cited by-同舟云学术

A phase 3 randomized clinical trial using a o nce‐weekly glucagon‐like peptide‐1 receptor agonist in adolescents and young adults with hypothalamic obesity

Published:2020-10-25 Issue:2 Volume:23 Page:363-373
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Roth Christian L.¹²^ORCID,Perez Francisco A.³,Whitlock Kathryn B.¹,Elfers Clinton¹,Yanovski Jack A.⁴,Shoemaker Ashley H.⁵,Abuzzahab M. Jennifer⁶

Affiliation:

1. Seattle Children's Research Institute Seattle Washington

2. Department of Pediatrics University of Washington Seattle Washington

3. Department of Radiology Seattle Children's and University of Washington Seattle Washington

4. Section on Growth and Obesity, Division of Intramural Research Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health Bethesda Maryland

5. Division of Pediatric Endocrinology Vanderbilt University Medical Center Nashville Tennessee

6. McNeely Pediatric Diabetes Center and Endocrinology Clinic Children's Minnesota St. Paul Minnesota

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14224

Reference38 articles.

1. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow‐up;Muller HL;Horm Res.,2008